Health Care/Hospital
Sihuan Pharmaceutical (0460.HK) receives approval for its exclusive medical aesthetic product Letybo (botulinum toxin), A blockbuster product in a hundred-billion size market
HONG KONG, Oct. 27, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460) is pleased announce that "Type A Botulinum Toxin for Injection" (Letybo 100U), a product exclusively distributed by Sihuan Pharmaceutical, has officially received the marketing approval from the Natio...
2020-10-27 10:42
6390
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study
MELBOURNE, Australia and SAN FRANCISCO, Oct. 26, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced it has commenced enrolling patients with Multiple System Atrophy (MSA) in its bioMUSE Study inthe United States. BioMUSE is a natur...
2020-10-27 10:03
3608
VeChain, Renji Hospital and DNV GL Held Strategic Partnership Signing Ceremony To Launch World's First Blockchain Intelligent Tumor Treatment Center
SHANGHAI, Oct. 27, 2020 /PRNewswire/ -- In partnership with VeChain and DNV GL, Renji Hospital, a top-ranked hospital inChinaaffiliated with the Shanghai Jiaotong University School of Medicine, has announced the launch of the world's first blockchain-enabled Intelligent Tumor Treatment Center on ...
2020-10-27 09:00
2636
VeChain, Renji Hospital and DNV GL Held Strategic Partnership Signing Ceremony To Launch World's First Blockchain Intelligent Tumor Treatment Center
SHANGHAI, Oct. 27, 2020 /PRNewswire/ -- In partnership with VeChain and DNV GL, Renji Hospital, a top-ranked hospital inChinaaffiliated with the Shanghai Jiaotong University School of Medicine, has announced the launch of the world's first blockchain-enabled Intelligent Tumor Treatment Center on ...
2020-10-27 09:00
2667
Ortho's VITROS® SARS-CoV-2 Antigen Test Capable of Accurate Mass-Scale Testing Achieves CE Mark
RARITAN, New Jersey, Oct. 27, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its new VITROS® SARS-CoV-2 Antigen test, designed to detect active SARS-CoV-2 infection, achieved CE Mark for distribution throughout the EU. The company al...
2020-10-27 08:50
1242
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Study of MDM2-p53 Inhibitor APG-115 in Combination with Immunotherapy for the Treatment of Patients with Advanced Liposarcoma or other Advanced Solid Tumors in China
SUZHOU, China and ROCKVILLE, Md., Oct. 27, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug Eva...
2020-10-27 08:13
2381
Drawbridge Health Announces Partnerships to Fuel Expansion in Japan
MENLO PARK, Calif., Oct. 27, 2020 /PRNewswire/ -- Drawbridge Health, a healthcare technology company redefining the blood draw experience for both patients and healthcare providers, today announced a further investment from Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon Pharma") as w...
2020-10-27 08:00
1650
Avidity Science™ Expands Biomedical Research Solutions Through Acquisition of Bio Medic Data Systems, Hydropac®, Lab Products, Inc., and Harford Systems
WATERFORD, Wisconsin, Oct. 27, 2020 /PRNewswire/ -- Today, Avidity Science announces significant steps in expanding its global leadership in biomedical research solutions via the acquisition of Bio Medic Data Systems, Hydropac®, Lab Products, Inc., and Harford Systems. These investments expand Av...
2020-10-27 08:00
2679
CStone and EQRx Enter Global Strategic Partnership for Two Immune Checkpoint Inhibitors: sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1)
* CStone to out-license to EQRx exclusive rights to two late-stage immuno-oncology assets for development and commercialization outside ofGreater China * Agreement provides a pathway to bring CStone's sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1) to global patient communities by partnering ...
2020-10-27 07:23
3522
USANA Malaysia named number one combination dietary supplements brand in the country by world-leading market research company
USANA Malaysia honored by Euromonitor International for second year in a row SALT LAKE CITY, Oct. 27, 2020 /PRNewswire/ -- To be recognized as the top company in your industry is an honor few achieve—one USANA Malaysia has earned for the second year in a row. USANA was recently named the No. 1 C...
2020-10-27 03:05
3235
Tegra Medical Announces Expansion in Europe and Asia
End-to-end contract manufacturing of medical devices to be extended to nine locations FRANKLIN, Massachusetts, Oct. 27, 2020 /PRNewswire/ -- Tegra Medical, a leading contract manufacturer of medical devices and a member of SFS, which is headquartered in Heerbrugg Switzerland, today announced it ...
2020-10-27 01:42
1841
Getinge launches NICCI - the latest innovation in Advanced Hemodynamic Monitoring
- NICCI is Getinge's latest innovation in Advanced Hemodynamic Monitoring, providing continuous and noninvasive hemodynamic insights to reduce the risk of severe complications for patients with low blood pressure GOTHENBURG, Sweden, Oct. 26, 2020 /PRNewswire/ -- Blood pressure is one of the most...
2020-10-26 21:34
3593
Reistone Biopharma Announces Positive Topline Results from Phase 2 Clinical Trial Evaluating SHR0302, a JAK1 Inhibitor for the Treatment of Moderate-to-Severe Atopic Dermatitis
* SHR0302 monotherapy achieved positive results on reaching primary endpoints with statistical significance, delivering significant improvements in skin clearance * Both doses were shown to be superior to placebo for key secondary endpoints * AEs were manageable and generally transient and r...
2020-10-26 19:40
1435
GMAX Biopharm gives first does of anti-body drug treating PAH in phase 1B trial
HANGZHOU, China, Oct. 26, 2020 /PRNewswire/ -- Gmax Biopharm today announces that the first dose of GMA301 was given to the patient in its phase1B trial to investigate the drug efficacy to treat pulmonary arterial hypertension (PAH). GMA 301 is the first antibody drug for PAH treatment. In the ph...
2020-10-26 18:00
1474
Sai Life Sciences to significantly expand biology capabilities at its integrated R&D campus
HYDERABAD, India, Oct. 26, 2020 /PRNewswire/ -- Sai Life Sciences, one of
India's fastest growing Contract Research, Development & Manufacturing
Organizations
2020-10-26 16:35
2196
RhoVac Participates in BIO Europe Digital
LUND, Sweden, Oct. 26, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today that it is participating this week in the partnering event BIO Europe 2020 Digital. This week the digital version of the massive pharmaceutical partnering conference BIO Europe is held with participation from RhoVac...
2020-10-26 16:26
1516
Article on RhoVac's Phase I/II study to be published in November
LUND, Sweden, Oct. 26, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today that the publication of the article on RhoVac's Phase I/II study is set to be published in November. As previously disclosed, the article elaborating on the results of RhoVac's Phase I/II study in prostate cancer in...
2020-10-26 15:51
1446
VISTA Eye Specialist collaborates with Award Winning Childrens' Books Publisher to provide "A Magical Christmas" 2020 celebrations
PETALING JAYA, Malaysia, Oct. 26, 2020 /PRNewswire/ -- To combat the growing Kids Myopia (shortsightedness) problem that is now reaching pandemic[1] heights, VISTA Eye Specialist (VISTA) is announcing a partnership with noted publisher 'The Five-A Alliance', to educate children on the importance ...
2020-10-26 14:04
2248
New Data On Mayne Pharma's Tolsura® (SUBA®-itraconazole) Presented At IDWeek 2020
ADELAIDE, Australia, Oct. 26, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that new clinical data has been presented on TOLSURA® (SUBA®-itraconazole) at IDWeek 2020, being held virtually in the US fromOctober 21st-25th. The conference is attended by over 11,50...
2020-10-26 12:10
3289
Eisai and Cogstate Expand Agreement for Global Development and Commercialization of Digital Cognitive Assessment Technologies
MELBOURNE, Australia, Oct. 26, 2020 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters:Tokyo, CEO: Haruo Naito, "Eisai") and Cogstate, Ltd. (Headquarters:Melbourne, Australia and New Haven, USA, CEO: Brad O'Connor, "Cogstate") announced today that the companies have entered into a collaboration where...
2020-10-26 08:37
1938
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 298 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
[Picked up by 284 media titles]
2024-11-29 20:33
MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Most Read
Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
2024-11-29 20:33
7064
Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
2024-11-26 13:00
5172